Recent News
Trimodality Therapy Increases Survival; Immunotherapy Treatment Approved by FDA
Since mesothelioma is often difficult to treat, scientists and researchers look to combination treatments and therapies to improve chances of patients’ survival. There is no “one” treatment that is used[…]
Read MoreMesothelioma Treatments Used Alongside Surgery – A Clinical Trial
Rare and aggressive in nature, mesothelioma is often a fatal cancer mainly due to its lack of response to most treatments. Surgical options have a higher chance of success for[…]
Read MoreAsbestos Fibers Just As Deadly Regardless of Size
Recognized as one of the six types of asbestos, tremolite is considered to be one of the more deadly forms of asbestos due to its long, sharp, needle-like fibers that[…]
Read MoreTwo Potential Mesothelioma Treatments Have No Positive Effect
Tremelimumab Earlier in the spring of 2017, scientists and researchers from the University of Salford in the UK published a special report questioning the effectiveness of the new immunotherapy treatment[…]
Read MoreImprovements in Radiation Therapies Give More Treatment Options
When it comes to different treatments for mesothelioma patients, there is no shortage of diversity, as options include chemotherapy, radiation, surgery, immune-based therapies, gene-based therapies, and more. Chemotherapy treatments cisplatin[…]
Read MoreMultiple Genetic Variants Increase Mesothelioma Risk
The term “high-risk predisposition,” is a well-known term in the cancer world that means a person could have certain genetic factors or other factors that places him or her at[…]
Read MoreMesothelioma Patients Receive Zoledronic Acid as Treatment
Known as a bisphosphonate, zoledronic acid is typically used for bone diseases such as osteoporosis, and to treat high calcium levels in the blood that can lead to other health[…]
Read MoreTime Increases Risk for Mesothelioma, Study Finds
Asbestos-related illnesses such as mesothelioma and asbestosis have been known to develop over a period of decades, affecting people years and years since their last exposure. Many studies over the[…]
Read MoreGiving Cediranib Another Chance
A Phase I study for cediranib, a VEGFR/PDGFR kinase inhibitor, showed promising results in shrinking tumor size and increasing survival rates for those suffering from malignant pleural mesothelioma. This is[…]
Read MoreCalretinin More Effective Than Mesothelin in Detecting Mesothelioma Early
Mesothelioma is a rare and aggressive cancer that is difficult to diagnose because symptoms often mimic other diseases such as pulmonary fibrosis or lung cancer. Pathology reports and biopsies help[…]
Read More